SG52674A1 - Human macrophage inflammatory protein 2-alpha - Google Patents

Human macrophage inflammatory protein 2-alpha

Info

Publication number
SG52674A1
SG52674A1 SG1996007666A SG1996007666A SG52674A1 SG 52674 A1 SG52674 A1 SG 52674A1 SG 1996007666 A SG1996007666 A SG 1996007666A SG 1996007666 A SG1996007666 A SG 1996007666A SG 52674 A1 SG52674 A1 SG 52674A1
Authority
SG
Singapore
Prior art keywords
alpha
inflammatory protein
macrophage inflammatory
human macrophage
human
Prior art date
Application number
SG1996007666A
Other languages
English (en)
Inventor
Carol Ann Gallegos
Patricia Tekamp-Olson
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of SG52674A1 publication Critical patent/SG52674A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG1996007666A 1990-06-22 1991-06-24 Human macrophage inflammatory protein 2-alpha SG52674A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54189790A 1990-06-22 1990-06-22
US71519491A 1991-06-19 1991-06-19

Publications (1)

Publication Number Publication Date
SG52674A1 true SG52674A1 (en) 1998-09-28

Family

ID=27066835

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996007666A SG52674A1 (en) 1990-06-22 1991-06-24 Human macrophage inflammatory protein 2-alpha

Country Status (7)

Country Link
EP (1) EP0536322A1 (fr)
JP (1) JPH06501381A (fr)
CA (1) CA2086091A1 (fr)
IE (1) IE66226B1 (fr)
PT (1) PT98072B (fr)
SG (1) SG52674A1 (fr)
WO (1) WO1992000327A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145676A (en) * 1981-09-08 1992-09-08 The Rockefeller University Method and agents for promoting wound healing
CA2092924A1 (fr) * 1990-09-28 1992-03-29 John Stephen Haskill Genes gro, proteines et leurs utilisations
US6447766B1 (en) 1993-06-08 2002-09-10 Smithkline Beecham Corporation Method of mobilizing hematopoietic stem cells
WO1994029341A1 (fr) * 1993-06-08 1994-12-22 Smithkline Beecham Corporation Procedes pour ameliorer la bioactivite de chimiokines
US6451562B1 (en) 1993-12-22 2002-09-17 Human Genome Sciences, Inc. Polypeptides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) polynucleotides
US6001606A (en) * 1994-03-08 1999-12-14 Human Genome Sciences, Inc. Polynucleotides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) and polypeptides encoded thereby
US6811773B1 (en) 1993-12-22 2004-11-02 Human Genome Sciences, Inc. Human monocyte colony inhibitory factor (M-CIF) polypeptides
US5504003A (en) * 1994-03-08 1996-04-02 Human Genome Sciences, Inc. Macrophage inflammatory protein-3 and -4
US6488925B2 (en) 1993-12-22 2002-12-03 Human Genome Sciences, Inc. Macrophage inflammatory protein-4 (MIP-4) polypeptides
US5874080A (en) * 1994-03-03 1999-02-23 Genentech, Inc. Anti-IL-8 monoclonal antibodies for treatment of asthma
US5686070A (en) * 1994-03-03 1997-11-11 Genentech, Inc. Methods for treating bacterial pneumonia
US6495129B1 (en) 1994-03-08 2002-12-17 Human Genome Sciences, Inc. Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3)
US5981231A (en) 1996-06-17 1999-11-09 Human Genome Sciences, Inc. Polynucleotides encoding chemokine β-15
KR100425016B1 (ko) * 2001-02-07 2004-03-27 주식회사 삼양사 용혈성 및 색소번짐 방지성이 우수한 폴리글리콜산 방사용처리제

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68928124T2 (de) * 1988-09-02 1997-10-16 Chiron Corp., Emeryville, Calif. Makrophagenabgeleiteter entzündungsmediator(mip-2)

Also Published As

Publication number Publication date
CA2086091A1 (fr) 1991-12-23
EP0536322A1 (fr) 1993-04-14
IE912192A1 (en) 1992-01-01
PT98072B (pt) 1998-11-30
WO1992000327A1 (fr) 1992-01-09
JPH06501381A (ja) 1994-02-17
IE66226B1 (en) 1995-12-13
PT98072A (pt) 1992-03-31

Similar Documents

Publication Publication Date Title
EP0550771A4 (en) Immunoglobulin-combining artificial protein
SG52674A1 (en) Human macrophage inflammatory protein 2-alpha
GB9115840D0 (en) Double ball joint
GB9003621D0 (en) Protein factor
GB9027728D0 (en) Novel protein
DE69434900D1 (de) Menschliche chemokin-polypeptide
AU111468S (en) An extruded member
AU115001S (en) An extrusion
AU111022S (en) An extrusion
AU110931S (en) an extrusion
AU109167S (en) An extrusion
AU112175S (en) An extrusion
AU111471S (en) An extrusion
AU111413S (en) An extrusion
AU111106S (en) an extrusion
AU110140S (en) An extrusion
AU109570S (en) An extrusion
AU110465S (en) An extrusion
IE901160L (en) Pp4-delta proteins
GB9017728D0 (en) Proteins
AU112632S (en) Extrusion
GB9007668D0 (en) Extrusion
AU112020S (en) Extrusion
AU112631S (en) Extrusion
AU110503S (en) Extrusion